Skip to content

Stroke Volume Variation and Pulse Pressure Variation as Predictors of Fluid Responsiveness During Kidney Transplantation

Utility of Stroke Volume Variation and Pulse Pressure Variation for Predicting Fluid Responsiveness in Chronic Renal Failure Patients Undergoing Kidney Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02459470
Enrollment
42
Registered
2015-06-02
Start date
2012-12-31
Completion date
2013-12-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

Fluid Responsiveness, Pulse Pressure Variation, Stroke Volume Variation

Brief summary

The aim pf this prospective study is to investigate the ability of stroke volume variation (SVV) and pulse pressure variation (PPV) to predict fluid responsiveness in patients undergoing kidney transplantation.

Detailed description

Optimal intraoperative fluid management guided by central venous pressure (CVP), a traditional intravascular volume status indicator has been established to improve transplanted graft function during renal transplantation. Recently, stroke volume variation (SVV) and pulse pressure variation (PPV), dynamic preload indices derived from the arterial waveform are increasingly advocated as predictors of fluid responsiveness in anesthetized patients and critically ill patients. However, their usefulness in renal failure patients undergoing renal transplantation has not been investigated. Thus, the aims of this study is to investigate accuracy of SVV and PPV for predicting fluid responsiveness in patients undergoing kidney transplantation.

Interventions

PROCEDUREFluid loading

fluid loading was performed by using 7ml/kg of 6% hydroxyethyl starch within 10 min to all patients

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

\- chronic renal failure patients undergoing renal transplantation

Exclusion criteria

* patients with cardiac arrhythmia * patients with reduced left ventricular function (EF \< 40%) * patients with valvular heart disease * patients intracardiac shunt * patients with pulmonary hypertension * patients with extensive peripheral vascular disease * patients with preoperative use of vasopressors or inotropics

Design outcomes

Primary

MeasureTime frameDescription
stroke volume variation from Flo stroke volume variation from FloTrac/Vigileo systemwithin 5 minutes after fluid expansionpredictable of stroke volume variation from FloTrac/Vigileo system for fluid responsiveness
pulse pressure variation from philips Intelivue MP70 monitorwithin 5 minutes after fluid expansionpredictable of pulse pressure variation from philips Intelivue MP70 monitor for fluid responsiveness

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026